A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcohol

Human Psychopharmacology

Volumn 24, Issue 6, 2009, Pages 465-472

  Kenna, George A ^a   Leggio, Lorenzo ^a   Swift, Robert M ^a,b  

^a BROWN UNIVERSITY   (United States)

^b PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alcohol; Alcohol dependence; Alcoholism; Aripiprazole; Lab studies; Topiramate

Indexed keywords

ARIPIPRAZOLE; TOPIRAMATE;

ADULT; AKINESIA; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DIARRHEA; DIZZINESS; DRUG ALCOHOL INTERACTION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVENING DOSAGE; FATIGUE; FEMALE; HEADACHE; HUMAN; INCREASED APPETITE; INSOMNIA; LIMB WEAKNESS; MALE; MORNING DOSAGE; PARESTHESIA; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SOMNOLENCE; TASTE DISORDER; TREATMENT OUTCOME; VOMITING; XEROSTOMIA;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PIPERAZINES; QUINOLONES; YOUNG ADULT;

EID: 70349545823     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1042     Document Type: Article

References (35)

1. Anton RF, Moak DH, Latham P. 1995. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 19: 92-99.
2. Anton RF, Kranzler H, Breder C, Marcus RN, Carson WH, Han J. 2008. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. J Clin Psychopharmacol 28: 5-12.
3. Babor TF, Biddle-Higgins JC, Saunders JB, Monteiro MG. 2001. AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. World Health Organization: New York, NY.
4. Bohn MJ, Krahn DD, Staehler BA. 1995. Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19: 600-606.
5. Bono G, Balducci C, Richelmi P, Koob GF, Pulvirenti L. 1996. Dopamine partial receptor agonists reduce ethanol intake in the rat. Eur J Pharm 296: 233-238.
6. Guy W. 1976. ECDEU Assessment Manual for Psychopharmacology. revised edition US Department of Health, Education, and Welfare: Washington, DC.
7. Hedlung JL, Veiweg BW. 1979. The Hamilton rating scale for depression. J Op Psych 10: 149-165.
8. Johnson BA, Ait-Daoud N, Bowden CL, et al. 2003. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361: 1677-1685.
9. Johnson BA, Rosenthal N, Capece JA, et al. 2007. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298: 1641-1651.
10. Johnson BA, Rosenthal N, Capece JA, et al. 2008. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med 168: 1188-1199.
11. Kenna GA. 2003. Rationale for use of aripiprazole for alcohol dependence treatment. Drugs Fut 28: 1227-1235.
12. Kenna GA, McGeary JE, Swift RM. 2004. Pharmacotherapy, pharmacogenomics and the future of alcohol dependence therapy. Am Health Sys Pharm 61: 2272-2279.
13. Kenna GA, Lomastro TL, Schiesl A, Leggio L, Swift RM. 2009. Topiramate: an anticonvulsant for alcohol dependence treatment. Current Drug Abuse Rev 2(2): 135-142.
14. Kranzler HR, Covault J, Pierucci-Lagha A, et al. 2008. Effects of aripiprazole on subjective and physiological responses to alcohol. Alcohol Clin Exp Res 32: 573-579.
15. Levine J, Schooler NR. 1986. SAFTEE; a technique for the systematic assessment of side effects in clinical trials. Psychopharm Bul 22: 343-381.
16. Martin CS, Earleywine M, Musty R, Perrine MW, Swift RM. 1993. Development and validation of the biphasic alcohol effects scale. Alcohol Clin Exp Res 17: 140-146.
17. Martinotti G, Nicola MD, Janiri L. 2007. Efficacy and safety of aripiprazole in alcohol dependence. Am J Drug Alc Abuse 33: 393-401.
18. Martinotti G, Di Nicola M, Di GiannantonioM, Janiri L. 2009. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. Naltrexone. J Psychopharm 23: 123-129.
19. McNair DM, Lorr M, Droppleman LF. 1971. Manual of the Profile of Mood States. Educational and Industrial Testing Service: San Diego, CA.
20. Miranda R Jr, MacKillop J, Monti PM, et al. 2008. Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Alcohol Clin Exp Res 32: 489-497.
21. Morrow AL, VanDoren MJ, Penland SN, Matthews DB. 2001. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence. Brain Res Rev 37: 98-109.
22. National Council on Alcohol. 1988. Recommended Council Guidelines on Ethyl Alcohol Administration in Human Experimentation. US. DHHS, ADAMHA: Rockville, MD.
23. Ortho-McNeil Neurologics Inc. 2005. Topamax ® package Insert. Raritan, NJ, Revised June 2005.
24. Otsuka Pharmaceutical Co. 2006. Abilify package insert. Tokyo, JN.
25. Papadeas S, Grobin AC, Morrow AL. 2001. Chronic ethanol consumption differentially alters GABA(A) receptor alpha1 and alpha4 subunit peptide expression and GABA(A) receptor-mediated 36 Cl(-) uptake in mesocorticolimbic regions of rat brain. Alcohol Clin Exp Res 25: 1270-1275.
26. Rabkin JG, Markowitz JS, Ocepek-Welikson K, Wager SS. 1992. General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research. J Clin Psychopharm 12: 3-10.
27. Sanchez-Craig M, Wilkinson DA, Davila R. 1995. Empirically based guidelines for moderate drinking: 1-year results from three studies with problem drinkers. Am J Pub Health 85: 823-828.
28. Singh GK, Kalmus GW, Björk AK, Myers RD. 1993. Alcohol drinking in rats is attenuated by the mixed 5-HT1 agonist/5-HT2 antagonist FG 5893. Alcohol 10: 243-248.
29. Sobell LC, Sobell MB. 1992. Timeline Follow-Back: a technique for assessing self reported alcohol consumption. In Measuring Alcohol Consumption: Psychological and Biological Methods. Litten RZ, Allen J (eds). Humana Press: Towota, NJ; 41-72.
30. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. 1989. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Bri J Addict 84: 1353-1357.
31. Swift RM. 2003. Topiramate for the treatment of alcohol dependence: initiating abstinence. Lancet 361: 1666-1667.
32. Van Oekelen D, Luyten WH, Leysen JE. 2003. 5-HT2A and 5-HT2C receptors and their atypical regulation properties. Life Sci 72: 2429-2449.
33. Voronin K, Randall P, Myrick H, Anton R. 2008. Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm-possible influence of self-control. Alcohol Clin Exp Res 32: 1954-1961.
34. Watson PE. 1989. Total body water and blood alcohol levels: Updating the fundamentals. In Human Metabolism of Alcohol: Pharmacokinetics, Medicolegal Aspects, and General Interest, K, Crow R Batt (eds). (Vol. 1) CRC Press: Boca Raton, FL; 41-58.
35. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. 2000. Topiramate modulates GABA-evoked currents in murine cortical neurons by nonbenzodiazepine mechanism. Epilepsia 41: S25-S29.